卓正医疗(02677)1月29日至2月3日招股 预计2月6日上市

Group 1 - The company,卓正医疗, plans to conduct an initial public offering (IPO) from January 29 to February 3, 2026, offering 4.75 million shares at a price range of HKD 57.7 to 66.6 per share, with 10% allocated for Hong Kong and 90% for international sales [1] - The company targets the high-end medical service market in China, focusing on affluent individuals with a disposable income exceeding RMB 200,000, and aims to provide personalized care [2] - The private high-end medical service market in China is projected to grow from RMB 193 billion in 2020 to RMB 426.3 billion by 2024, with a compound annual growth rate (CAGR) of 21.9%, and is expected to reach RMB 831.4 billion by 2029, growing at a CAGR of 14.3% [2] Group 2 - The company operates 19 medical service institutions in China, including 17 clinics and 2 hospitals, and has plans for further expansion through organic growth and strategic acquisitions [3] - The company has secured cornerstone investment agreements totaling USD 11.64 million from several investors, which will be used to purchase shares at the IPO price [3] - The estimated net proceeds from the IPO, assuming a median price of HKD 62.15 per share, will be approximately HKD 219 million, allocated for various purposes including AI application development, upgrading existing facilities, and potential acquisitions [4]